Sun Pharma gets FDA acceptance for Cranbury manufacturing palnt.

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Autopack to host biggest packaging machinery stand at PPMA Total 2025

Leading independent integrator of packaging lines Autopack will showcase a range...

Bionova Scientific Opens US pDNA Development Facility

The 10,000 ft.² Woodlands site is located near Houston...

The FDA PreCheck Program To Speed-Up US Drug Production

The US Food and Drug Administration announced on August...

Reshoring Amidst Tariff Cloud – Aurobindo Acquires Lannett

Aurobindo acquires Lannett – the US Drugmaker for $250...

Sun Pharmaceutical has received the US Food and Drug Administration (FDA) acceptance for its manufacturing plant at Cranbury in New Jersey, US.

Earlier, the company has received a warning letter from the agency on 25 August 2010 for violating good manufacturing practice regulations. The issuance of the letter follows FDA inspection of the site.

Caraco, now wholly owned by Sun Pharma, continues to work with consultants to resolve the issues raised by the FDA at its Detroit plant.

Latest stories

Related stories

Autopack to host biggest packaging machinery stand at PPMA Total 2025

Leading independent integrator of packaging lines Autopack will showcase a range...

Bionova Scientific Opens US pDNA Development Facility

The 10,000 ft.² Woodlands site is located near Houston...

The FDA PreCheck Program To Speed-Up US Drug Production

The US Food and Drug Administration announced on August...

Reshoring Amidst Tariff Cloud – Aurobindo Acquires Lannett

Aurobindo acquires Lannett – the US Drugmaker for $250...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back